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White blood cell count to mean platelet volume ratio 
as a novel blood cell parameter. Authors’ reply
We would like to thank Çelik et al. [1] for 
the reply to our article “White blood cell count to 
mean platelet volume ratio: A novel and promis-
ing prognostic marker for ST-segment elevation 
myocardial infarction” [2]. Herein, we wish to make 
some contributions to their valuable comments. As 
previously stated, there is a strong discussion on 
the relationship between blood cell parameters and 
outcomes in patients with coronary artery disease 
(CAD) [3–5]. These parameters can be useful in 
predicting the prognosis in patients with acute 
coronary syndromes (ACS). It is noteworthy, that 
novel biomarkers measured by clinicians could 
potentially provide additional information to the 
decision-making process and treatment strategy 
[4]. Indeed, there is growing body of research sup-
porting the hypothesis that white blood cell count 
to mean platelet volume ratio (WMR) could be 
a new prognostic indicator that contains these three 
properties [2, 6]. However, long-term follow-up and 
large-scale prospective further studies are strongly 
needed to clarify and prove the predictive value of 
WMR in patients with CAD and ACS.
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